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We herein wish to provide data additional to those reported in our previous review 
(Tsolaki et al1) concerning the association between Helicobacter pylori (  H. pylori)   
infection and primary open-angle glaucoma. These data were not available in the time 
period when the review paper was submitted and accepted for publication, and we 
believe that they need to be added because they further reinforce this association.
In our new study published this year,2 we show for the first time the existence of 
H. pylori bacteria in the trabeculum and iris specimens of glaucoma patients, thereby 
further supporting the role for H. pylori infection in the pathophysiology of primary 
open-angle glaucoma. Specifically, the study included 51 consecutive patients who 
underwent trabeculectomy for primary open-angle glaucoma not responsive to topical 
antiglaucoma therapy. The presence of H. pylori was established by upper gastrointes-
tinal endoscopy and histology, or by a urea breath test in eight patients who either were 
deemed not suitable endoscopy candidates or refused to undergo endoscopy.
All the patients underwent a surgical trabeculectomy procedure to their eyes,   during 
which tissue samples from the trabeculum, conjunctiva, and iris were immediately 
obtained, placed in tubes containing 10% formalin, and submitted for histological 
examination. These specimens were stained using the Cresyl fast violet method 
(for detection of H. pylori organisms). In five patients, for whom gastric H. pylori 
histology was positive, we managed to identify H. pylori bacteria in the trabeculum 
and iris specimens histologically with Cresyl fast violet stain for the first time. The 
reason why H. pylori was not found in the trabeculum and iris of all primary open-
angle glaucoma patients who tested positive for H. pylori status could be explained, 
apart from the absence of H. pylori in the eye, by the very small size of the sample of 
tissue obtained and submitted for histopathology during trabeculectomy, or possibly 
by standard local antisepsis prior to surgery. Despite the small number of cases, the 
findings of this study are important because H. pylori bacteria have been detected for 
the first time in the trabeculum and iris of patients with primary open-angle glaucoma, 
confirming that the bacterium is present locally, and is possibly directly implicated 
in glaucomatous damage.
In a second study just accepted for publication,3 we obtained biopsy specimens at 
upper gastrointestinal endoscopy from 43 patients with primary open-angle glaucoma, 
which were then evaluated for the presence of H. pylori, for expression of genes 
involved in cell proliferation and apoptosis (Ki-67, p53, Bcl-2), and for indices of 
cellular immune surveillance (Τ lymphocytes [TLs] and B lymphocytes [BLs]). Of the 
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43 patients eligible for upper gastrointestinal endoscopy, 
90.7% tested positive for H. pylori infection. Ki-67 was 
positively expressed in 81.25% of patients with H. pylori 
infection and in one patient without H. pylori infection. p53 
was positively expressed in 31.25% of patients with H. pylori 
infection but not in those without H. pylori infection. Bcl-2 
was positively expressed in 68.75% of patients with H. pylori 
infection and in one patient without H. pylori infection. 
Ki-67, p53, and Bcl-2 were overexpressed in 19%, 25%, and 
37.5%, respectively, of patients with H. pylori infection, but 
none was overexpressed in the patients without H. pylori 
infection. The TL marker was positively expressed in all 
patients with H. pylori infection and in the one patient without 
H. pylori infection. The BL marker was positively expressed 
only in one patient with H. pylori infection. Therefore, 
our forthcoming article provides further evidence that the 
Η. pylori-induced oncogenes, Ki-67, p53 and Bcl-2, as well 
as TL markers are involved in cell proliferation and apoptotic 
pathways, thereby contributing to glaucomatous neuropathy, 
with oncogenic potential. In this respect, and apart from 
the apoptotic processes involved in the pathophysiology of 
glaucomatous neuropathy, recent experimental data indicate 
that cell proliferation rather than astrocyte hypertrophy 
  characterizes early pressure-induced optic nerve head injury, 
and the optic nerve head is the principal site of initial axonal 
injury in glaucoma. Furthermore, at the eye level, Ki-67 has 
been used as an index of melanoma proliferation and also 
as an index showing response to treatment with agents that 
inhibit the proliferation of Tenon’s fibroblasts, decreasing 
excessive scarring after trabeculectomy.2
Specifically, we have also very recently provided an 
overview of the various pathophysiological mechanisms 
underlying the association between H. pylori infection and 
primary open-angle glaucoma4 which include: promoting 
platelet and platelet-leukocyte aggregation, also involved in 
the pathophysiology of glaucoma; releasing proinflammatory 
and  vasoactive  substances,  including  cytokines 
(interleukins-1, -6, -8, -10, and -12, tumor necrosis 
factor alpha [TNF-α], interferon-gamma), eicosanoids 
(leukotrienes, prostaglandins) and acute-phase proteins 
(fibrinogen, C-reactive protein) involved in vascular 
disorders and glaucoma; stimulating mononuclear cells 
to induce tissue factor-like procoagulant activity that 
converts fibrinogen into fibrin; causing the development 
of cross-mimicry between endothelial and H. pylori 
antigens; producing oxidative stress and circulating lipid 
peroxides; and in particular influencing the apoptotic 
process, parameters of which may also exert their own effects 
in the induction and/or progression of glaucoma and other 
neurodegenerative disorders (Guillain–Barré syndrome, 
Alzheimer’s disease, Parkinson’s disease) associated with 
both H. pylori infection and glaucoma.
Importantly, H. pylori infection and glaucoma share the 
Fas/FasL and mitochondria-mediated apoptotic pathways, 
thereby suggesting an apoptotic link in the   pathophysiology of 
both diseases. In particular, increased endothelin-1 (a potent 
constrictor of arterioles and venules), nitric oxide, and induc-
ible nitric oxide synthase levels are associated with H. pylori 
infection. Endothelin-1-induced anterior optic nerve vessel 
vasoconstriction and vascular tone modulation by nitric oxide 
in the ophthalmic artery may produce glaucomatous damage. 
Moreover, nitric oxide, a rapidly diffusing gas, is a potent 
neurotoxin that may facilitate apoptotic retinal ganglion cell 
death in glaucomatous optic neuropathy. Support for the 
consideration of nitric oxide neurotoxicity in glaucoma is 
provided by experimental evidence demonstrating that retinal 
ganglion cell apoptosis is attenuated by   neutralizing antibod-
ies against TNF-α or by selective   inhibitors of inducible 
nitric oxide synthase, thereby suggesting that the inhibitors 
of TNF-α or of the inducible isoform (NOS-2) may provide 
novel therapeutic targets for neuroprotection in the treatment 
of glaucomatous optic neuropathy.
In addition, systemic H. pylori-induced oxidative damage 
may be the mechanism which links oxidative stress, H. pylori 
infection, and the apoptotic damage to the trabecular mesh-
work and optical nerve head that results in glaucoma. In this 
regard, oxidative stress is an essential underlying cause of 
neuroinflammatory and neurodegenerative diseases, includ-
ing glaucoma and the blood–brain barrier damage connected 
to these diseases; oxidative stress activates protein tyrosine 
kinase and matrix metalloproteinases, resulting in blood–
brain barrier dysfunction.4
H. pylori infection, by releasing several inflammatory 
mediators,5 could induce breakdown of the blood–brain/
blood–ocular barriers, thereby being involved in the patho-
genesis of neuropathies, including glaucoma.5 For instance, 
H. pylori could indirectly affect the brain through the 
release of TNF-α acting at a distance; TNF-α is involved 
in blood–brain barrier disruption through upregulation 
of matrix metalloproteinases. Furthermore, circulating 
antibodies for H. pylori might also enter the aqueous cir-
culation due to disruption of the blood–brain/blood–ocular 
barriers,   possibly contributing to the pathophysiology of 
glaucoma; when serum-specific antibodies access the brain, 
they are capable of killing retinal cells.5 Likewise, an influx of 
H. pylori-infected monocytes, owing to defective autophagy 
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resulting in H. pylori replication in autophagic vesicles, 
through the disrupted blood–brain/blood–ocular barrier, 
might lead to glaucoma neuropathy. H. pylori VacA cytotoxin 
promotes intracellular survival of the bacterium and modu-
lates host immune responses.5 In addition, because the oral 
cavity might act as a permanent reservoir for H. pylori, this 
bacterium may reach the eye through the nasal cavity, causing 
ophthalmic pathologies, possibly including glaucoma.5 
Finally, it is important to note that studies conducted in 
Korea, China, India, Turkey, and Iran have also reported an 
association between H. pylori infection and glaucoma.2
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